当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析

科前生物

(688526)

  

流通市值:84.70亿  总市值:84.70亿
流通股本:4.66亿   总股本:4.66亿

科前生物(688526)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.87亿元,每股收益0.18元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益390367.90万元,未分配利润202193.77万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产461838.41万元,负债71470.51万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入204,929,240.41,064,074,588.89827,439,173.94531,839,356.71
营业总成本117,548,562.59547,826,665.17407,570,296.65263,731,462.07
营业利润100,624,673.5459,131,690.91412,743,443.37276,689,466.17
利润总额100,009,570.54457,580,664.5411,654,477.45275,005,589.86
净利润87,075,680.66395,580,552.7357,180,085.48238,976,717.5
其他综合收益3,322,297.4725,333,622.92--
综合收益总额90,397,978.13420,914,175.62357,180,085.48238,976,717.5
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,472,776,254.392,566,086,573.762,973,386,605.592,794,077,981.5
非流动资产合计2,145,607,824.282,105,162,897.251,764,357,049.251,737,438,733.79
资产总计4,618,384,078.674,671,249,471.014,737,743,654.844,531,516,715.29
流动负债合计637,309,672.55758,252,066.9845,705,990.93725,283,757.57
非流动负债合计77,395,391.8375,340,080.38124,422,903.64156,821,565.43
负债合计714,705,064.38833,592,147.28970,128,894.57882,105,323
归属于母公司股东权益合计3,901,801,603.233,835,627,197.553,765,793,758.43,647,531,472.52
股东权益合计3,903,679,014.293,837,657,323.733,767,614,760.273,649,411,392.29
负债和股东权益合计4,618,384,078.674,671,249,471.014,737,743,654.844,531,516,715.29
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计276,340,855.261,131,870,298.28910,354,099.44553,229,405.97
经营活动现金流出小计143,254,275.52593,836,368.39464,708,550.15331,765,669.62
经营活动产生的现金流量净额133,086,579.74538,033,929.89445,645,549.29221,463,736.35
投资活动现金流入小计446,189,764.612,043,866,185.89918,287,031.32529,467,209.98
投资活动现金流出小计220,764,662.942,372,862,356.981,103,959,733.45746,817,039.36
投资活动产生的现金流量净额225,425,101.67-328,996,171.09-185,672,702.13-217,349,829.38
筹资活动现金流入小计50,059,095.89344,118,858.75260,000,000165,000,000
筹资活动现金流出小计177,480,673.8446,544,220.24315,061,968.21208,180,146.78
筹资活动产生的现金流量净额-127,421,577.91-102,425,361.49-55,061,968.21-43,180,146.78
汇率变动对现金及现金等价物的影响0.0654,930.5--
现金及现金等价物净增加额231,090,103.56106,667,327.81204,910,878.95-39,066,239.81
期末现金及现金等价物余额788,458,886.5557,368,782.94655,612,334.08411,635,215.32
最新报告期:2024-04-29
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华泰证券熊承慧0.971.211.462024-04-29
兴业证券纪宇泽1.111.411.612024-04-11
西南证券徐卿1.261.521.712024-04-09
东兴证券程诗月1.011.251.462024-04-08
国信证券李瑞楠,鲁家瑞1.081.431.362024-04-08
TOP↑